Literature DB >> 26937135

Estrogen receptors in gastric cancer: Advances and perspectives.

Muhammad Saif Ur Rahman1, Jiang Cao1.   

Abstract

Worldwide, gastric cancer is one of the most common malignancies with high mortality. Various aspects of the development and progression of gastric cancer continue to be extensively investigated in order to further our understanding and provide more effective means for the prevention, diagnosis, and treatment of the disease. Estrogen receptors (ERs) are steroid hormone receptors that regulate cellular activities in many physiological and pathological processes in different tissues. There are two distinct forms of ERs, namely ERα and ERβ, with several alternative-splicing isoforms for each. They show distinct tissue distribution patterns and exert different biological functions. Dysregulation of ERs has been found to be associated closely with many diseases, including cancer. A number of studies have been conducted to investigate the role of ERs in gastric cancer, the possible mechanisms underlying these roles, and the clinical relevance of deregulated ERs in gastric cancer patients. To date, inconsistent associations of different ERs with gastric cancer have been reported. These inconsistencies may be caused by variations in in vitro cell models and clinical samples, including assay conditions and protocols with regard to different forms of ERs. Given the potential of the deregulated ERs as diagnostic/prognostic markers or therapeutic targets for gastric cancer, it will be important to identify/confirm the association of each ER isoform with gastric cancer, to determine the specific roles and interactions that these individual ER isoforms play under specific conditions in the development and/or progression of gastric cancer, and to elucidate precisely these mechanisms. In this review, we summarize the achievements from early ER studies in gastric cancer to the most up-to-date discoveries, with an effort to provide a comprehensive understanding of the role of ERs roles in gastric cancer and its possible mechanisms. Furthermore, we propose directions for future investigations.

Entities:  

Keywords:  Carcinogenesis; Estrogen receptor; Gastric cancer; Genomic pathway; Isoform; Mechanism; Non-genomic pathway

Mesh:

Substances:

Year:  2016        PMID: 26937135      PMCID: PMC4768193          DOI: 10.3748/wjg.v22.i8.2475

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  59 in total

Review 1.  Estrogen receptor α and hedgehog signal pathway developmental biology of gastric adenocarcinoma.

Authors:  Chaoyang Xu; Jiajia Li; Yangyang Lu; Zhinong Jiang
Journal:  Hepatogastroenterology       Date:  2012-06

2.  Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer.

Authors:  C Y Xu; J L Guo; Z N Jiang; S D Xie; J G Shen; J Y Shen; L B Wang
Journal:  Ann Surg Oncol       Date:  2010-03-26       Impact factor: 5.344

3.  Estrogen binding by neoplastic human thymus cytosol.

Authors:  F O Ranelletti; M Carmignani; P Marchetti; C Natoli; S Iacobelli
Journal:  Eur J Cancer       Date:  1980-07       Impact factor: 9.162

4.  Involvement of ER-α36 in the malignant growth of gastric carcinoma cells is associated with GRP94 overexpression.

Authors:  Zhengqi Fu; Hao Deng; Xuming Wang; Xiuping Yang; Zhaoyi Wang; Lijiang Liu
Journal:  Histopathology       Date:  2013-07-08       Impact factor: 5.087

5.  Estrogen receptors in gastric adenocarcinoma: a retrospective immunohistochemical analysis.

Authors:  H Yokozaki; N Takekura; A Takanashi; J Tabuchi; R Haruta; E Tahara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

Review 6.  Src in cancer: deregulation and consequences for cell behaviour.

Authors:  Margaret C Frame
Journal:  Biochim Biophys Acta       Date:  2002-06-21

7.  A variant of estrogen receptor-alpha, ER-alpha36 is expressed in human gastric cancer and is highly correlated with lymph node metastasis.

Authors:  Hao Deng; Xuan Huang; Jun Fan; Liubai Wang; Qin Xia; Xiuping Yang; Zhaoyi Wang; Lijiang Liu
Journal:  Oncol Rep       Date:  2010-07       Impact factor: 3.906

8.  Estrogen-receptor protein in intracranial meningiomas.

Authors:  M S Donnell; G A Meyer; W L Donegan
Journal:  J Neurosurg       Date:  1979-04       Impact factor: 5.115

9.  Overexpression of ERα inhibits proliferation and invasion of MKN28 gastric cancer cells by suppressing β-catenin.

Authors:  Jichun Zhou; Rongyue Teng; Chaoyang Xu; Qinchuan Wang; Jufeng Guo; Chenpu Xu; Ziduo Li; Shuduo Xie; Jianguo Shen; Linbo Wang
Journal:  Oncol Rep       Date:  2013-07-09       Impact factor: 3.906

10.  Diverse animal models to examine potential role(s) and mechanism of endocrine disrupting chemicals on the tumor progression and prevention: Do they have tumorigenic or anti-tumorigenic property?

Authors:  Min-Ah Park; Kyung-A Hwang; Kyung-Chul Choi
Journal:  Lab Anim Res       Date:  2011-12-19
View more
  19 in total

1.  Estrogen receptor-α36-mediated rapid estrogen signaling regulates 78 kDa glucose-regulated protein expression in gastric carcinoma cells.

Authors:  Zhengqi Fu; Xuming Wang; Zhaoyi Wang; Lijiang Liu
Journal:  Oncol Lett       Date:  2018-04-19       Impact factor: 2.967

2.  Gastrointestinal Tract Metastases of Invasive Lobular Carcinoma of the Breast: An Immunohistochemical Survey Algorithm.

Authors:  Baha Zengel; Demet Çavdar; Özlem Özdemir; Funda Taşlı; Murat Karataş; Cenk Şimşek; Adam Uslu
Journal:  Eur J Breast Health       Date:  2022-10-01

3.  Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer.

Authors:  Jia Gao; Sifu Yang; Guanqun Xie; Jieli Pan; Feiye Zhu
Journal:  Drug Des Devel Ther       Date:  2022-06-20       Impact factor: 4.319

4.  Inhibitors Targeting Multiple Janus Kinases From Zanthoxylum simulans Mediate Inhibition and Apoptosis Against Gastric Cancer Cells via the Estrogen Pathway.

Authors:  Yong-Qiang Tian; Dai Hu; Yong-Li Zhang; Jian Zou; Gui-Lin Chen; Ming-Quan Guo
Journal:  Front Chem       Date:  2022-06-06       Impact factor: 5.545

5.  Expression profile of E-cadherin, estrogen receptors, and P53 in early-onset gastric cancers.

Authors:  Fan Zhou; Yuanyuan Xu; Jiong Shi; Xing Lan; Xiaoping Zou; Lei Wang; Qin Huang
Journal:  Cancer Med       Date:  2016-10-25       Impact factor: 4.452

6.  Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis.

Authors:  Janaki K Iyer; Mamta Kalra; Anil Kaul; Mark E Payton; Rashmi Kaul
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

7.  mRNA expression of steroidogenic enzymes, steroid hormone receptors and their coregulators in gastric cancer.

Authors:  Bartosz Adam Frycz; Dawid Murawa; Maciej Borejsza-Wysocki; Mateusz Wichtowski; Arkadiusz Spychała; Ryszard Marciniak; Paweł Murawa; Michał Drews; Paweł Piotr Jagodziński
Journal:  Oncol Lett       Date:  2017-03-21       Impact factor: 2.967

8.  Periampullary Metastases from Breast Cancer: A Case Report and Literature Review.

Authors:  Yi Lin; Sio In Wong; Yuzhou Wang; Chileong Lam; Xianghong Peng
Journal:  Case Rep Oncol Med       Date:  2019-01-09

9.  Cisplatin resistance in gastric cancer cells is involved with GPR30-mediated epithelial-mesenchymal transition.

Authors:  Xiaofeng Wang; Zhiyuan Xu; Jiancheng Sun; Hang Lv; Yiping Wang; Yixiu Ni; Shangqi Chen; Can Hu; Lijing Wang; Wei Chen; Xiangdong Cheng
Journal:  J Cell Mol Med       Date:  2020-02-12       Impact factor: 5.310

Review 10.  Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.

Authors:  Tamás Deli; Mónika Orosz; Attila Jakab
Journal:  Pathol Oncol Res       Date:  2019-01-08       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.